The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Open accessAbstract
SOX2 (Sex-determining region Y (SRY)-Box2) has important functions during embryonic development and is involved in cancer stem cell (CSC) maintenance, in which it impairs cell growth and tumorigenicity. However, the function of SOX2 in pancreatic cancer cells is unclear. The objective of this study was to analyze SOX2 expression in human pancreatic tumors and determine the role of SOX2 in pancreatic cancer cells regulating CSC properties. In this report, we show that SOX2 is not expressed in normal pancreatic acinar or ductal cells. However, ectopic expression of SOX2 is observed in 19.3% of human pancreatic tumors. SOX2 knockdown in pancreatic cancer cells results in cell growth inhibition via cell cycle arrest associated with p21(Cip1) and p27(Kip1) induction, whereas SOX2 overexpression promotes S-phase entry and cell proliferation associated with cyclin D3 induction. SOX2 expression is associated with increased levels of the pancreatic CSC markers ALDH1, ESA and CD44. Importantly, we show that SOX2 is enriched in the ESA(+)/CD44(+) CSC population from two different patient samples. Moreover, we show that SOX2 directly binds to the Snail, Slug and Twist promoters, leading to a loss of E-Cadherin and ZO-1 expression. Taken together, our findings show that SOX2 is aberrantly expressed in pancreatic cancer and contributes to cell proliferation and stemness/dedifferentiation through the regulation of a set of genes controlling G1/S transition and epithelial-to-mesenchymal transition (EMT) phenotype, suggesting that targeting SOX2-positive cancer cells could be a promising therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Self-citationHermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Multipotent cell lineages in early mouse development depend on SOX2 function
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N., & Lovell-Badge, R. (2003) · Genes & Development · doi:10.1101/gad.224503 · Cited by 2,369
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Bass, A. J., Watanabe, H., Mermel, C. H., Yu, S., Perner, S., Verhaak, R. G., Kim, S. Y., Wardwell, L., Tamayo, P., Gat-Viks, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.465 · Cited by 942
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 863
Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells
Yamanaka, S. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.05.012 · Cited by 740
Li, Y., VandenBoom, T. G., Kong, D., Wang, Z., Ali, S., Philip, P. A., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1298 · Cited by 663
Chew, J.-L., Loh, Y.-H., Zhang, W., Chen, X., Tam, W.-L., Yeap, L.-S., Li, P., Ang, Y.-S., Lim, B., Robson, P., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6031-6046.2005 · Cited by 646
Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma
Bar, E. E., Chaudhry, A., Lin, A., Fan, X., Schreck, K., Matsui, W., Piccirillo, S., Vescovi, A. L., DiMeco, F., Olivi, A., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0166 · Cited by 607
Sox2 expression in breast tumours and activation in breast cancer stem cells
Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., Pandiella, A., Rezola, R., & Martin, A. G. (2012) · Oncogene · doi:10.1038/onc.2011.338 · Cited by 514
EMT as the ultimate survival mechanism of cancer cells
Tiwari, N., Gheldof, A., Tatari, M., & Christofori, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.013 · Cited by 512
Hotz, B., Arndt, M., Dullat, S., Bhargava, S., Buhr, H.-J., & Hotz, H. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2926 · Cited by 418
Lonardo, E., Hermann, P. C., Mueller, M.-T., Huber, S., Balic, A., Miranda-Lorenzo, I., Zagorac, S., Alcala, S., Rodriguez-Arabaolaza, I., Ramirez, J. C., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.001 · Cited by 405
Sex determination and SRY: down to a wink and a nudge?
Sekido, R., & Lovell-Badge, R. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.10.008 · Cited by 316
Hussenet, T., Dali, S., Exinger, J., Monga, B., Jost, B., Dembelé, D., Martinet, N., Thibault, C., Huelsken, J., Brambilla, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008960 · Cited by 296
Kim, M. P., Fleming, J. B., Wang, H., Abbruzzese, J. L., Choi, W., Kopetz, S., McConkey, D. J., Evans, D. B., & Gallick, G. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020636 · Cited by 290
Plk Is an M-Phase-Specific Protein Kinase and Interacts with a Kinesin-Like Protein, CHO1/MKLP-1
Lee, K. S., Yuan, Y.-L. O., Kuriyama, R., & Erikson, R. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7143 · Cited by 268
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas
Basu-Roy, U., Seo, E., Ramanathapuram, L., Rapp, T. B., Perry, J. A., Orkin, S. H., Mansukhani, A., & Basilico, C. (2012) · Oncogene · doi:10.1038/onc.2011.405 · Cited by 238
All purpose Sox: The many roles of Sox proteins in gene expression
Wegner, M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.006 · Cited by 231
Alonso, M. M., Diez-Valle, R., Manterola, L., Rubio, A., Liu, D., Cortes-Santiago, N., Urquiza, L., Jauregi, P., de Munain, A. L., Sampron, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026740 · Cited by 215
Otsubo, T., Akiyama, Y., Yanagihara, K., & Yuasa, Y. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604193 · Cited by 208
Floor, S., van Staveren, W. C. G., Larsimont, D., Dumont, J. E., & Maenhaut, C. (2011) · Oncogene · doi:10.1038/onc.2011.184 · Cited by 204
Lonardo, E., Frias-Aldeguer, J., Hermann, P. C., & Heeschen, C. (2012) · Cell Cycle · doi:10.4161/cc.19679 · Cited by 181
Xiang, R., Liao, D., Cheng, T., Zhou, H., Shi, Q., Chuang, T. S., Markowitz, D., Reisfeld, R. A., & Luo, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.94 · Cited by 174
Eberl, M., Klingler, S., Mangelberger, D., Loipetzberger, A., Damhofer, H., Zoidl, K., Schnidar, H., Hache, H., Bauer, H., Solca, F., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100201 · Cited by 165
Chen, S., Xu, Y., Chen, Y., Li, X., Mou, W., Wang, L., Liu, Y., Reisfeld, R. A., Xiang, R., Lv, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036326 · Cited by 160
Han, X., Fang, X., Lou, X., Hua, D., Ding, W., Foltz, G., Hood, L., Yuan, Y., & Lin, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041335 · Cited by 155
Hage, C., Rausch, V., Giese, N. A., Giese, T., Schönsiegel, F., Labsch, S., Nwaeburu, C. C., Mattern, J., Gladkich, J., & Herr, I. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.158 · Cited by 125
Giorgetti, A., Montserrat, N., Rodríguez‐Pizà, I., Azqueta, C., Veiga, A., & Belmonte, J. C. I. (2010) · Nature Protocols · doi:10.1038/nprot.2010.16 · Cited by 104
Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition
Venkatesha, V. A., Parsels, L. A., Parsels, J. D., Zhao, L., Zabludoff, S., Simeone, D. M., Maybaum, J., Lawrence, T. S., & Morgan, M. A. (2012) · Neoplasia · doi:10.1593/neo.12538 · Cited by 91
Self-citationPancreatic cancer spheres are more than just aggregates of stem marker-positive cells
Gaviraghi, M., Tunici, P., Valensin, S., Rossi, M., Giordano, C., Magnoni, L., Dandrea, M., Montagna, L., Ritelli, R., Scarpa, A., et al. (2010) · Bioscience Reports · doi:10.1042/bsr20100018 · Cited by 78
Heterogeneity and Targeting of Pancreatic Cancer Stem Cells
Penchev, V. R., Rasheed, Z. A., Maitra, A., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3112 · Cited by 72
Shimoda, M., Sugiura, T., Imajo, I., Ishii, K., Chigita, S., Seki, K., Kobayashi, Y., & Shirasuna, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-377 · Cited by 60
Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells
Cox, J. L., Wilder, P. J., Desler, M. M., & Rizzino, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044087 · Cited by 54
Evidence for the presence of stem cell-like progenitor cells in human adult pancreas
Zhao, M., Amiel, S. A., Christie, M. R., Muiesan, P., Srinivasan, P., Littlejohn, W., Rela, M., Arno, M. J., Heaton, N. D., & Huang, G. C. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0436 · Cited by 50
p73 cooperates with Ras in the activation of MAP kinase signaling cascade
Fernandez-Garcia, B., Vaqué, J. P., Herreros-Villanueva, M., Marques-Garcia, F., Castrillo, F., Fernandez-Medarde, A., León, J., & Marín, M. C. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401945 · Cited by 25
Self-citationWhite, M. G., Alturaifi, H. R., Holliman, G., Aldibbiat, A. M., Mahmoud, A., & Shaw, J. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0123 · Cited by 16
Eradicating cancer cells: struggle with a chameleon
Di, J., Boer, T. D., Figdor, C. G., & Torensma, R. (2011) · Oncotarget · doi:10.18632/oncotarget.222 · Cited by 16
Research works printed but not linked: 3
- Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y . Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 2006; 32: 164–170. · doi:10.1097/01.mpa.0000202947.80117.a0
- Pietanza MC, Ladanyi M . Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet 2012; 44: 1074–1075. · doi:10.1038/ng.2415
- Zhang JS, Koenig A, Young C, Billadeau DD . GRB2 couples RhoU to epidermal growth factor receptor signaling and cell migration. Mol Biol Cell 2011; 22: 2119–2130. · doi:10.1091/mbc.e10-12-0969
Cited by
Krebs, A. M., Mitschke, J., Lasierra Losada, M., Schmalhofer, O., Boerries, M., Busch, H., Boettcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 975
Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G. E., Barrett, A. S., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 603
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Shamloo, B., & Usluer, S. (2019) · Cancers · doi:10.3390/cancers11081178 · Cited by 336
Metadata
- Authors
- Herreros-Villanueva, M., Zhang, J.-S., Koenig, A., Abel, E. V., Smyrk, T. C., Bamlet, W. R., de Narvajas, A. A.-M., Gomez, T. S., Simeone, D. M., Bujanda, L., & Billadeau, D. D.
- Venue
- Oncogenesis
- Published
- 2013-08-05
- Volume
- 2
- Issue
- 8
- Pages
- e61-e61
- ISSN
- 2157-9024 (ISSN-L)
- OpenAlex
- W2054786727
- Cited by
- 331
- References
- 47
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.